| Literature DB >> 26019957 |
Mahmoud M Shalaby1, Adel Kurkar1, Mohamed A Zarzour1, Amr A Faddan1, Mahmoud Khalil1, Mohamed F Abdelhafez1.
Abstract
OBJECTIVES: To report the findings and management of patients with persistent Müllerian duct syndrome (PMDS). PATIENTS AND METHODS: Nineteen phenotypically male patients (aged 8 months to 27 years) presented with testicular maldescent. All of them had normal male external genitalia. Two of them had had a previous diagnosis of persistent Müllerian structures. All patients were karyotyped, and had a hormonal profile, diagnostic laparoscopy, retrograde urethrocystogram, gonadal biopsies, and surgical management according to the findings. The follow-up was based on a clinical examination, abdominal ultrasonography (US) and scrotal colour-Doppler US at 3 and 6 months after surgery, and every 6 months thereafter.Entities:
Keywords: AFP, α-fetoprotein; AMH, anti-Müllerian hormone; AMHR-II, anti-Müllerian hormone type II receptor; Cryptorchidism; DSD, disorders of sexual development; Disorders of sexual development; FSO, Fowler-Stephens orchidopexy; LDH, lactate dehydrogenase; LH, luteinising hormone; Laparoscopic orchidopexy; Müllerian duct; PMDS, persistent Müllerian duct syndrome; hCG, human chorionic gonadotrophin
Year: 2014 PMID: 26019957 PMCID: PMC4435512 DOI: 10.1016/j.aju.2014.04.001
Source DB: PubMed Journal: Arab J Urol ISSN: 2090-598X
Figure 1A consistent testicular abnormality; yellowish-brown cystic areas.
Figure 2The excised Müllerian structures.
A comparison of the age of patients who had their Müllerian structures excised with the age of those who had them left intact.
| Variable | Excised | Intact | |
|---|---|---|---|
| N patients | 10 | 9 | – |
| Mean (range) | 5.1 (0.66–11) | 11.8 (1.25–27) | 0.042 |
| Age (years) | |||
| Primary | 17 | 1 | |
| Staged FSO | 0 | 14 | <0.001 |
A comparison of the initial to final testicular volumes (measured by the Prader orchidometer) and scrotal US.
| Sample | Mean (range) testicular volume (mL) |
|---|---|
| At 3 months | 3.1 (0.43–14.6) |
| Final | 3.9 (0.54–14.7) |
| <0.001 | |
| Intraoperative | 3.5 (1–15) |
| Final | 4.3 (1–15) |
| <0.001 | |
Figure 3The size and vascularity of Müllerian structures from 15-month-old (right) and 22-year-old (left) patients.